当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3718203
自主品牌
已选条件
-
T18331MC-VC-PABC-DNA31；化合物 T18331MC-VC-PABC-DNA31
MC-VC-PABC-DNA31 is a drug-linker conjugate designed for Antibody-Drug Conjugates (ADC) that demonstrates potent antitumor activity. It employs DNA31, an effective inhibitor of RNA polymerase, connected through the MC-VC-PABC ADC linker.
价 格：￥电议型 号：T18331产 地：中国大陆
-
T18330MC-Val-Cit-PAB-vinblastine；化合物 T18330MC-Val-Cit-PAB-vinblastine
MC-Val-Cit-PAB-vinblastine is a potent antitumor drug-linker conjugate for Antibody-Drug Conjugates (ADC), featuring vinblastine (a microtubule protein inhibitor) connected through the MC-Val-Cit-PAB ADC linker.
价 格：￥电议型 号：T18330产 地：中国大陆
-
T18329MC-VC(S)-PABQ-Tubulysin M；化合物 T18329MC-Val-Cit-PAB-tubulysin5a；MC-Val-Cit-PAB-tubulysin5a
MC-Val-Cit-PAB-tubulysin5a is a drug-linker conjugate for ADC with potent antitumor activity by using tubulysin5a (a tubulin inhibitor), linked via the ADC linker MC-Val-Cit-PAB.
价 格：￥电议型 号：T18329产 地：中国大陆
-
T18328MC-Val-Cit-PAB-rifabutin；化合物 T18328MC-Val-Cit-PAB-rifabutin
MC-Val-Cit-PAB-rifabutin is a drug-linker conjugate designed for antibody-drug conjugates (ADC), featuring the potent antitumor agent rifabutin (a DNA-dependent RNA polymerase inhibitor) connected through the MC-Val-Cit-PAB ADC linker. This configuration endows it with significant antitumor activity.
价 格：￥电议型 号：T18328产 地：中国大陆
-
T18327MC-Val-Cit-PAB-Retapamulin；化合物 T18327MC-Val-Cit-PAB-Retapamulin
MC-Val-Cit-PAB-Retapamulin is a drug-linker conjugate for antibody-drug conjugates (ADC) that exhibits potent antitumor activity. This compound utilizes Retapamulin, a ribosome inhibitor, connected through the ADC linker MC-Val-Cit-PAB.
价 格：￥电议型 号：T18327产 地：中国大陆
-
T18326MC-Val-Cit-PAB-MMAF；化合物 T18326MC-Val-Cit-PAB-MMAF
MC-Val-Cit-PAB-MMAF is an antibody-drug conjugate (ADC) component that exhibits antitumor properties through the action of the tubulin inhibitor, monomethyl auristatin F (MMAF), which is connected by a cathepsin-cleavable linker, MC-Val-Cit-PAB.
价 格：￥电议型 号：T18326产 地：中国大陆
-
T18324MC-Val-Cit-PAB-duocarmycin chloride；化合物 T18324MC-Val-Cit-PAB-duocarmycin；MC-Val-Cit-PAB-duocarmycin
MC-Val-Cit-PAB-duocarmycin is an antibody-drug conjugate (ADC) linker that combines duocarmycin, a potent DNA minor groove-binding alkylating agent, with an antitumor drug through the MC-Val-Cit-PAB linker, exhibiting significant antitumor activity.
价 格：￥电议型 号：T18324产 地：中国大陆
-
T18323MC-Val-Cit-PAB-dimethylDNA31；化合物 T18323MC-Val-Cit-PAB-dimethylDNA31
MC-Val-Cit-PAB-dimethylDNA31 is a drug-linker conjugate employed in antibody-drug conjugates (ADCs) that exhibits robust antitumor efficacy. This conjugate utilizes the ADC linker, MC-Val-Cit-PAB, to link to the potent antitumor agent dimethylDNA31. Notably, dimethylDNA31 also demonstrates significant bactericidal activity against both persister and stationary-phase Staphylococcus aureus.
价 格：￥电议型 号：T18323产 地：中国大陆
-
T18322MC-Val-Cit-PAB-clindamycin；化合物 T18322MC-Val-Cit-PAB-clindamycin
MC-Val-Cit-PAB-clindamycin is an antibody-drug conjugate (ADC) linker that combines the potent antitumor properties of clindamycin, a protein synthesis inhibitor, with the ADC linker MC-Val-Cit-PAB, to enhance its ability to target and kill cancer cells effectively.
价 格：￥电议型 号：T18322产 地：中国大陆
-
T18321Mc-Val-Cit-PAB-Cl；化合物Mc-Val-Cit-PAB-ClMc-Val-Cit-PAB-Cl
Mc-Val-Cit-PAB-Cl, a cleavable ADC linker, is utilized in the conjugation of MMAE and antibodies to produce compounds such as antibody-MC-vc-MMAE (e.g., anti-CD22-MC-VC-PABC-MMAE), which demonstrate cytotoxicity with IC50s of 3.3 and 0.95 nM against BJAB and WSU cell lines, respectively.
价 格：￥电议型 号：T18321产 地：中国大陆
-
T18320MC-Val-Cit-PAB-carfilzomib iodide；化合物 T18320MC-Val-Cit-PAB-carfilzomib；MC-Val-Cit-PAB-carfilzomib
MC-Val-Cit-PAB-carfilzomib is a potent antitumor drug-linker conjugate for antibody-drug conjugates (ADC), comprising the irreversible proteasome inhibitor carfilzomib, connected through the ADC linker MC-Val-Cit-PAB.
价 格：￥电议型 号：T18320产 地：中国大陆
-
T18319MC-Val-Cit-PAB-Auristatin E；化合物 T18319MC-Val-Cit-PAB-Auristatin E
MC-Val-Cit-PAB-Auristatin E is an antibody-drug conjugate (ADC) linker compound featuring Auristatin E, a potent cytotoxic tubulin modifier, connected through the MC-Val-Cit-PAB linker, exhibiting significant antitumor activity.
价 格：￥电议型 号：T18319产 地：中国大陆
-
T18318MC-Val-Ala-PAB-PNP；化合物MC-Val-Ala-PAB-PNPinhibit|||ADC Linkers|||Inhibitor|||MC Val Ala PAB PNP|||Ant
MC-Val-Ala-PAB-PNP is a cleavable ADC linker. MC-Val-Ala-PAB-PNP can be used in the synthesis of antibody-drug conjugates (ADCs).
价 格：￥电议型 号：T18318产 地：中国大陆
-
T18316MC-Sq-Cit-PAB-Gefitinib；化合物 T18316MC-Sq-Cit-PAB-Gefitinib
MC-Sq-Cit-PAB-Gefitinib is a potent antitumor drug-linker conjugate for Antibody-Drug Conjugates (ADC), utilizing Gefitinib—an EGFR tyrosine kinase inhibitor—connected through the MC-Sq-Cit-PAB ADC linker.
价 格：￥电议型 号：T18316产 地：中国大陆
-
T18315MC-Sq-Cit-PAB-Dolastatin10；化合物 T18315MC-Sq-Cit-PAB-Dolastatin10
MC-Sq-Cit-PAB-Dolastatin10 is a potent antitumor drug-linker conjugate for Antibody-Drug Conjugates (ADC), utilizing Dolastatin10 (a tubulin polymerization inhibitor) connected through the MC-Sq-Cit-PAB ADC linker.
价 格：￥电议型 号：T18315产 地：中国大陆
-
T18305Mal-VC-PAB-DM1；化合物 T18305Mal-VC-PAB-DM1
Mal-VC-PAB-DM1, a drug-linker conjugate for antibody-drug conjugates (ADCs), exhibits potent antitumor activity. It incorporates DM1, a potent microtubule-disrupting agent, connected through the ADC linker Mal-VC-PAB [1].
价 格：￥电议型 号：T18305产 地：中国大陆
-
T18304Mal-VC-PAB-ABAEP-Azonafide；化合物 T18304Mal-VC-PAB-ABAEP-Azonafide|||MalVCPABABAEPAzonafide|||Mal VC PA
Mal-VC-PAB-ABAEP-Azonafide, an ADC (antibody-drug conjugate) linker-drug conjugate, demonstrates potent antitumor activity. It incorporates Azonafide, a cytotoxin, connected through the ADC linker Mal-VC-PAB[1].
价 格：￥电议型 号：T18304产 地：中国大陆
-
T18303Mal-Phe-C4-VC-PAB-MMAE；化合物 T18303Mal-Phe-C-4-VC-PAB-MMAE|||Mal Phe C4 VC PAB MMAE|||Mal-Phe-C4-VC-PA
Mal-Phe-C4-VC-PAB-MMAE is a chemical compound resulting from the conjugation of monomethyl auristatin E (MMAE), a potent tubulin inhibitor serving as a toxin payload in antibody-drug conjugates, with a Mal-Phe-C4-VC-PAB linker.
价 格：￥电议型 号：T18303产 地：中国大陆
-
T18302Mal-Phe-C4-VC-PAB-DMEA-PNU-159682；化合物 T18302Mal Phe C4 VC PAB DMEA PNU 159682|||Mal-Phe-C4-VC-PAB-DM
Mal-Phe-C4-VC-PAB-DMEA-PNU-159682 is a drug-linker conjugate utilized in antibody-drug conjugate (ADC) therapy. It comprises the ADC linker Mal-Phe-C4-VC-PAB and the potent ADC cytotoxin DMEA-PNU-159682. DMEA-PNU-159682 encompasses metabolites of nemorubicin (MMDX) derived from liver microsomes, as well as the ADC cytotoxin PNU-159682[1].
价 格：￥电议型 号：T18302产 地：中国大陆
-
T18301Mal-Phe-C4-Val-Cit-PAB；化合物 T18301Mal-Phe-C4-Val-Cit-PAB
Mal-Phe-C4-Val-Cit-PAB is a cleavable antibody-drug conjugate (ADC) linker featuring a Maleimide functional group. It is employed in the synthesis of ADCs.
价 格：￥电议型 号：T18301产 地：中国大陆
